Results 221 to 230 of about 161,133 (312)
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency. [PDF]
Wang C +19 more
europepmc +1 more source
This study presents a novel strategy for periodontitis treatment by co‐delivering a membrane‐ and ribosome‐targeting antimicrobial peptide GF and Irisin through a pH‐responsive metal‐organic framework. The system enables sequential release, providing rapid antibacterial action, anti‐inflammatory and antioxidative effects, as well as promoting bone ...
Yan Chen +10 more
wiley +1 more source
Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle? [PDF]
Chau CA, Cyr SL, Gupta R, Lio P.
europepmc +1 more source
The Microbiology and Immunology of Normal Physiologic Birth: A Plea for the Nature of Mother [PDF]
Hanson, Lisa, VandeVusse, Leona
core +1 more source
ABSTRACT Postpartum hemorrhage (PPH) remains the leading cause of preventable maternal mortality despite standard interventions. Recent fibrinogen trials failed to improve outcomes, prompting interest in coagulation factor XIII (FXIII). FXIII functions as “molecular cement,” cross‐linking fibrin and stabilizing clots.
Jeremy W. Jacobs +8 more
wiley +1 more source
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers. [PDF]
Chandrakasan S +26 more
europepmc +1 more source
ABSTRACT Acute chest syndrome (ACS) is one of the most common severe complications of sickle cell disease (SCD). In recent years, a major role of inflammation and innate immunity has been evidenced, but ACS pathophysiology remains incompletely understood, and therapeutic options are limited.
Slimane Allali +14 more
wiley +1 more source
Advancing equity in allergy and immunology: progress, pitfalls, and the path forward. [PDF]
Mendez P +3 more
europepmc +1 more source
ABSTRACT Sickle cell disease (SCD) is a chronic inflammatory state, characterized by increased plasma values of inflammatory and angiogenic proteins. Although red blood cell (RBC) transfusion is known to have immunomodulatory effects in other conditions, its potential effects on the inflammatory state in SCD remain largely unknown.
Lydian A. de Ligt +9 more
wiley +1 more source

